What's New

2014-04-16

HKSH Pioneer Clinical Study for Peanut Allergy in Hong Kong - A New Customized Desensitization Treatment for Peanut Allergic Patient

A pilot study conducted by Hong Kong Sanatorium & Hospital’s Allergy Centre has found that a dual treatment approach combining the use of anti-IgE (omalizumab, a drug that reduces allergic reaction) and oral desensitization has been successful in increasing tolerance for peanuts in patients suffering from peanut allergy. Even if they accidentally ingest peanut-containing foods, allergic reaction will not appear easily, thus their lives are protected.

Please click here for more information. 

 


FRAUD ALERT: Reports have been received from the public about fraudulent calls impersonating Hong Kong Sanatorium & Hospital, falsely claiming uncollected medical documents. Do not respond or share personal information. Please be aware of bogus communications (fraudulent websites, emails and phone calls) purportedly from HKSH Medical Group or its members including Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern Medical Centre, HKSH Cancer Centre and affiliates. Do not disclose any personal information to suspicious calls. Please call HKSH Medical Group at 2572 0211 if you have any concerns.

find us on     YouTube     Instagram     Wechat